2699828-16-3
2699828-16-3
Chemical Structure
Indacaterol-d3
- CAS No.: 2699828-16-3
- Formula:C24H25D3N2O3
- Molecular Weight:395.51
IUPAC Name: 5-((1R)-2-((5-ethyl-6-(ethyl-2,2,2-d3)-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
InChIKey: QZZUEBNBZAPZLX-WBCYSTDTSA-N
SMILES: CCC(C=C(C1)C(CC1NC[C@@H](C2=C3C(NC(C=C3)=O)=C(C=C2)O)O)=C4)=C4CC([2H])([2H])[2H]
Biological Activity: Indacaterol-d3 is deuterium labeled Indacaterol.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Indacaterol-d3 | Indacaterol-d3 is deuterium labeled Indacaterol. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Indacaterol (Standard) | 99.98% | Indacaterol (Standard) is the analytical standard of Indacaterol. This product is intended for research and analytical applications. Indacaterol is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol can also be used in cardiovascular disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Indacaterol | 99.98% | Indacaterol is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol can also be used in cardiovascular disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
